These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 1903808

  • 1. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.
    Geis GS, Stead H, Wallemark CB, Nicholson PA.
    J Rheumatol Suppl; 1991 Mar; 28():11-4. PubMed ID: 1903808
    [Abstract] [Full Text] [Related]

  • 2. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G, Lazzaroni M, Petrillo M.
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [Abstract] [Full Text] [Related]

  • 3. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
    Agrawal NM, Saggioro A.
    J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754
    [Abstract] [Full Text] [Related]

  • 4. Misoprostol prevents NSAID-induced gastroduodenal lesions in patients with osteoarthritis and rheumatoid arthritis.
    Saggioro A, Alvisi V, Blasi A, Dobrilla G, Fioravanti A, Marcolongo R.
    Ital J Gastroenterol; 1991 Mar; 23(3):119-23. PubMed ID: 1742504
    [Abstract] [Full Text] [Related]

  • 5. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
    Bocanegra TS, Weaver AL, Tindall EA, Sikes DH, Ball JA, Wallemark CB, Geis GS, Fort JG.
    J Rheumatol; 1998 Aug; 25(8):1602-11. PubMed ID: 9712107
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diclofenac/misoprostol: the European clinical experience.
    McKenna F.
    J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of misoprostol in upper gastro-intestinal lesions in arthritic patients on non-steroidal anti-inflammatory drugs (NSAIDS)--an Indian experience.
    Bhatt CB, Pipalia DH, Naik SR, Tilve GH.
    J Postgrad Med; 1988 Oct; 34(4):224-8. PubMed ID: 3151214
    [No Abstract] [Full Text] [Related]

  • 10. Misoprostol in the prevention of NSAID-induced gastric ulcer: a multicenter, double-blind, placebo-controlled trial.
    Roth SH.
    J Rheumatol Suppl; 1990 Feb; 20():20-4. PubMed ID: 2109073
    [Abstract] [Full Text] [Related]

  • 11. Prevention of gastrointestinal complications associated with nonsteroidal antiinflammatory drugs.
    Agrawal NM, Aziz K.
    J Rheumatol Suppl; 1998 May; 51():17-20. PubMed ID: 9596550
    [Abstract] [Full Text] [Related]

  • 12. [Sulglicotide in the prevention of gastric disease induced by NSAID. Double-blind controlled study versus placebo].
    Magarò M, Altomonte L, Zoli A, Mirone L, Wielmarin A, Massari M, Destito G, Nazzari M, Psilogenis M.
    Minerva Dietol Gastroenterol; 1989 May; 35(1):27-30. PubMed ID: 2725926
    [Abstract] [Full Text] [Related]

  • 13. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
    Wilson DE.
    Postgrad Med J; 1988 May; 64 Suppl 1():7-11. PubMed ID: 3138683
    [Abstract] [Full Text] [Related]

  • 14. Misoprostol: a prostaglandin for peptic ulcer.
    DiPalma JR.
    Am Fam Physician; 1989 Aug; 40(2):217-9. PubMed ID: 2502901
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevention of nonsteroidal anti-inflammatory drug-induced gastropathy: clinical and economic implications of a single-tablet formulation of diclofenac/misoprostol.
    Goldstein JL, Larson LR, Yamashita BD.
    Am J Manag Care; 1998 May; 4(5):687-97. PubMed ID: 10179922
    [Abstract] [Full Text] [Related]

  • 17. Cost effectiveness of replacing diclofenac with a fixed combination of misoprostol and diclofenac in patients with rheumatoid arthritis.
    Kristiansen IS, Kvien TK, Nord E.
    Arthritis Rheum; 1999 Nov; 42(11):2293-302. PubMed ID: 10555023
    [Abstract] [Full Text] [Related]

  • 18. [Therapy of non-steroidal antirheumatic drug-induced gastrointestinal lesions with misoprostol].
    Bach GL, Stock KP, Hüdepohl M.
    Z Rheumatol; 1991 Nov; 50(3):175-80. PubMed ID: 1927064
    [Abstract] [Full Text] [Related]

  • 19. Recent advances in defining the role of misoprostol in rheumatology.
    Nicholson PA.
    J Rheumatol Suppl; 1990 Feb; 20():50-3. PubMed ID: 2109076
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of misoprostol in the prophylaxis of gastroduodenal lesions induced by short-term nonsteroidal antiinflammatory drug therapy in elderly patients. A multicenter double-blind, placebo-controlled trial.
    Piette F, Teillet L, Naudin R, Boichut D, Capron MH.
    Rev Rhum Engl Ed; 1997 Apr; 64(4):259-66. PubMed ID: 9178399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.